179 related articles for article (PubMed ID: 11159748)
21. Formation and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol enantiomers in vitro in mouse, rat and human tissues.
Upadhyaya P; Carmella SG; Guengerich FP; Hecht SS
Carcinogenesis; 2000 Jun; 21(6):1233-8. PubMed ID: 10837015
[TBL] [Abstract][Full Text] [Related]
22. Quantitation of microsomal alpha-hydroxylation of the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.
Peterson LA; Mathew R; Hecht SS
Cancer Res; 1991 Oct; 51(20):5495-500. PubMed ID: 1913670
[TBL] [Abstract][Full Text] [Related]
23. Tumorigenicity and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol enantiomers and metabolites in the A/J mouse.
Upadhyaya P; Kenney PM; Hochalter JB; Wang M; Hecht SS
Carcinogenesis; 1999 Aug; 20(8):1577-82. PubMed ID: 10426810
[TBL] [Abstract][Full Text] [Related]
24. Cell specificity for the pulmonary metabolism of tobacco-specific nitrosamines in the Fischer rat.
Belinsky SA; White CM; Trushin N; Hecht SS
Carcinogenesis; 1989 Dec; 10(12):2269-74. PubMed ID: 2591016
[TBL] [Abstract][Full Text] [Related]
25. Metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the patas monkey: pharmacokinetics and characterization of glucuronide metabolites.
Hecht SS; Trushin N; Reid-Quinn CA; Burak ES; Jones AB; Southers JL; Gombar CT; Carmella SG; Anderson LM; Rice JM
Carcinogenesis; 1993 Feb; 14(2):229-36. PubMed ID: 8435864
[TBL] [Abstract][Full Text] [Related]
26. Analysis of human urine for pyridine-N-oxide metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific lung carcinogen.
Carmella SG; Borukhova A; Akerkar SA; Hecht SS
Cancer Epidemiol Biomarkers Prev; 1997 Feb; 6(2):113-20. PubMed ID: 9037562
[TBL] [Abstract][Full Text] [Related]
27. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in isolated rat lung and liver.
Schrader E; Hirsch-Ernst KI; Richter E; Foth H
Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar; 357(3):336-43. PubMed ID: 9550307
[TBL] [Abstract][Full Text] [Related]
28. Analysis of CYP2A contributions to metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in human peripheral lung microsomes.
Brown PJ; Bedard LL; Reid KR; Petsikas D; Massey TE
Drug Metab Dispos; 2007 Nov; 35(11):2086-94. PubMed ID: 17717079
[TBL] [Abstract][Full Text] [Related]
29. Effect of phenethyl isothiocyanate on the metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by cultured rat lung tissue.
Doerr-O'Rourke K; Trushin N; Hecht SS; Stoner GD
Carcinogenesis; 1991 Jun; 12(6):1029-34. PubMed ID: 2044181
[TBL] [Abstract][Full Text] [Related]
30. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human kidney epithelial cells transfected with rat CYP2B1 cDNA.
Lacroix D; Desrochers M; Castonguay A; Anderson A
Carcinogenesis; 1993 Aug; 14(8):1639-42. PubMed ID: 8353848
[TBL] [Abstract][Full Text] [Related]
31. Quantitation of pyridylhydroxybutyl-DNA adducts in liver and lung of F-344 rats treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and enantiomers of its metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol.
Upadhyaya P; Kalscheuer S; Hochalter JB; Villalta PW; Hecht SS
Chem Res Toxicol; 2008 Jul; 21(7):1468-76. PubMed ID: 18570389
[TBL] [Abstract][Full Text] [Related]
32. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by cytochrome P450IIB1 in a reconstituted system.
Guo Z; Smith TJ; Ishizaki H; Yang CS
Carcinogenesis; 1991 Dec; 12(12):2277-82. PubMed ID: 1747927
[TBL] [Abstract][Full Text] [Related]
33. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by human cytochrome P450 1A2 and its inhibition by phenethyl isothiocyanate.
Smith TJ; Guo Z; Guengerich FP; Yang CS
Carcinogenesis; 1996 Apr; 17(4):809-13. PubMed ID: 8625495
[TBL] [Abstract][Full Text] [Related]
34. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in mouse lung microsomes and its inhibition by isothiocyanates.
Smith TJ; Guo ZY; Thomas PE; Chung FL; Morse MA; Elkind K; Yang CS
Cancer Res; 1990 Nov; 50(21):6817-22. PubMed ID: 2208146
[TBL] [Abstract][Full Text] [Related]
35. Metabolism and DNA single strand breaks induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and its analogues in primary culture of rat hepatocytes.
Liu LL; Alaoui-Jamali MA; el Alami N; Castonguay A
Cancer Res; 1990 Mar; 50(6):1810-6. PubMed ID: 2306734
[TBL] [Abstract][Full Text] [Related]
36. Purification and characterization of oxidoreductases-catalyzing carbonyl reduction of the tobacco-specific nitrosamine 4-methylnitrosamino-1-(3-pyridyl)-1-butanone (NNK) in human liver cytosol.
Atalla A; Breyer-Pfaff U; Maser E
Xenobiotica; 2000 Aug; 30(8):755-69. PubMed ID: 11037109
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of stereospecifically deuterated 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) iastereomers and metabolism by A/J mouse lung microsomes and cytochrome p450 2A5.
Jalas JR; Hecht SS
Chem Res Toxicol; 2003 Jun; 16(6):782-93. PubMed ID: 12807362
[TBL] [Abstract][Full Text] [Related]
38. Biotransformation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in freshly isolated human lung cells.
Smith GB; Castonguay A; Donnelly PJ; Reid KR; Petsikas D; Massey TE
Carcinogenesis; 1999 Sep; 20(9):1809-18. PubMed ID: 10469628
[TBL] [Abstract][Full Text] [Related]
39. The identification of 11 beta-hydroxysteroid dehydrogenase as carbonyl reductase of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.
Maser E; Richter E; Friebertshäuser J
Eur J Biochem; 1996 Jun; 238(2):484-9. PubMed ID: 8681962
[TBL] [Abstract][Full Text] [Related]
40. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a tobacco-specific carcinogen, by rabbit nasal microsomes and cytochrome P450s NMa and NMb.
Hong JY; Ding X; Smith TJ; Coon MJ; Yang CS
Carcinogenesis; 1992 Nov; 13(11):2141-4. PubMed ID: 1423886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
